Announced
Completed
Financials
Tags
Private
Single Bidder
Spain
Private Equity
Pharmaceuticals
Friendly
artificial sweeteners
Acquisition
flavourings
Majority
Completed
Cross Border
Synopsis
The Riverside Company, a private equity firm completed an investment in HealthTech BioActives, a manufacturer of active pharmaceutical ingredients. Financial terms were not disclosed. “There is incredible potential in the flavor industry for us. We’re excited to help accelerate HTBA’s new product development, driving sales and increasing its existing product portfolio during our hold," Damien Gaudin, Riverside Principal.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.